1,790
Views
27
CrossRef citations to date
0
Altmetric
Reviews

An updated review of antidepressants with marked serotonergic effects in obsessive–compulsive disorder

, , MD PhD, , , &

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Verônica Hühne, Carina Chacur, Marcos Vinícius Sousa de Oliveira, Pedro Pereira Fortes, Gabriela M. Bezerra de Menezes & Leonardo F. Fontenelle. (2023) Considerations for the treatment of obsessive-compulsive disorder in patients who have comorbid major depression. Expert Review of Neurotherapeutics 23:11, pages 955-967.
Read now
Alexander V. Kulikov, Raul R. Gainetdinov, Evgeni Ponimaskin, Allan V. Kalueff, Vladimir S. Naumenko & Nina K. Popova. (2018) Interplay between the key proteins of serotonin system in SSRI antidepressants efficacy. Expert Opinion on Therapeutic Targets 22:4, pages 319-330.
Read now
Jana Vyskocilova, Jan Prasko & Jiri Sipek. (2016) Cognitive behavioral therapy in pharmacoresistant obsessive–compulsive disorder. Neuropsychiatric Disease and Treatment 12, pages 625-639.
Read now

Articles from other publishers (23)

Livio Tarchi, Giuseppe Pierpaolo Merola, Ottone Baccaredda‐Boy, Francesca Arganini, Emanuele Cassioli, Eleonora Rossi, Mario Maggi, David S. Baldwin, Valdo Ricca & Giovanni Castellini. (2023) Selective serotonin reuptake inhibitors, post‐treatment sexual dysfunction and persistent genital arousal disorder: A systematic review. Pharmacoepidemiology and Drug Safety 32:10, pages 1053-1067.
Crossref
Christopher Pittenger, Brian P. Brennan, Lorrin Koran, Carol A. Mathews, Gerald Nestadt, Michele Pato, Katharine A. Phillips, Carolyn I. Rodriguez, H. Blair Simpson, Petros Skapinakis, Dan J. Stein & Eric A. Storch. (2021) Specialty knowledge and competency standards for pharmacotherapy for adult obsessive-compulsive disorder. Psychiatry Research 300, pages 113853.
Crossref
Bushra M. Shah & Susan G. Kornstein. 2021. How Sex and Gender Impact Clinical Practice. How Sex and Gender Impact Clinical Practice 153 169 .
Gulen Guler Aksu, Pinar Akdere Dogdu, Pelin Dag, Meryem Ozlem Kutuk & Fevziye Toros. (2020) Safe and Effective Use of Venlafaxine, Mirtazapine, and Aripiprazole in an Adolescent with Treatment-Resistant Obsessive-Compulsive Disorder. Psychiatric Annals 50:11, pages 509-512.
Crossref
Hui-Rong Guo, Bai-Ling Huang, Ya-Li Wang, Yan-Yan Zhang, Quan-Gang Ma, Pei-Pei Lv & Yu-Ming Ren. (2020) Effect of Escitalopram on Serum GDNF and BDNF Levels and 5-HT Level of Brain Tissue of Obsessive–Compulsive Disorder Rats. Cellular and Molecular Neurobiology 40:6, pages 991-997.
Crossref
Daniel Lustberg, Alexa F. Iannitelli, Rachel P. Tillage, Molly Pruitt, L. Cameron Liles & David Weinshenker. (2020) Central norepinephrine transmission is required for stress-induced repetitive behavior in two rodent models of obsessive-compulsive disorder. Psychopharmacology 237:7, pages 1973-1987.
Crossref
Meredith E. Coles & Matthew H. Goodman. (2020) A systematic review of case studies testing a melatonergic agonist/ 5HT2c antagonist for individuals with obsessive compulsive disorder. Journal of Anxiety Disorders 69, pages 102173.
Crossref
Summer L. Thompson & Stephanie C. Dulawa. (2019) Dissecting the roles of β-arrestin2 and GSK-3 signaling in 5-HT1BR-mediated perseverative behavior and prepulse inhibition deficits in mice. PLOS ONE 14:2, pages e0211239.
Crossref
Roland SeifertRoland Seifert. 2019. Basic Knowledge of Pharmacology. Basic Knowledge of Pharmacology 331 344 .
Elisabetta Burchi, Eric Hollander & Stefano Pallanti. (2018) From Treatment Response to Recovery: A Realistic Goal in OCD. International Journal of Neuropsychopharmacology 21:11, pages 1007-1013.
Crossref
Katherine E. Williams & Hristina Koleva. (2018) Identification and Treatment of Peripartum Anxiety Disorders. Obstetrics and Gynecology Clinics of North America 45:3, pages 469-481.
Crossref
F. Caraci, F. Calabrese, R. Molteni, L. Bartova, M. Dold, G. M. Leggio, C. Fabbri, J. Mendlewicz, G. Racagni, S. Kasper, M. A. Riva & F. Drago. (2018) International Union of Basic and Clinical Pharmacology CIV: The Neurobiology of Treatment-resistant Depression: From Antidepressant Classifications to Novel Pharmacological Targets. Pharmacological Reviews 70:3, pages 475-504.
Crossref
Tom MunyerMegan J. Ehret. 2017. PharmacotherapyFirst: A Multimedia Learning Resource. PharmacotherapyFirst: A Multimedia Learning Resource.
Tom Munyer. 2017. PharmacotherapyFirst: A Multimedia Learning Resource. PharmacotherapyFirst: A Multimedia Learning Resource.
Sandra Iurescia, Davide Seripa & Monica Rinaldi. (2015) Role of the 5-HTTLPR and SNP Promoter Polymorphisms on Serotonin Transporter Gene Expression: a Closer Look at Genetic Architecture and In Vitro Functional Studies of Common and Uncommon Allelic Variants. Molecular Neurobiology 53:8, pages 5510-5526.
Crossref
Bin Feng, Zhang-Jin Zhang, Rui-Ming Zhu, Guo-Zhen Yuan, Li-Yuan Luo, Grainne M. McAlonan, Fang-Zhong Xu, Jiong Chen, Lan-Ying Liu, Yang-Yang Lv, Hei Kiu Wong, Ying Zhang & Li-Xia Zhu. (2016) Transcutaneous electrical acupoint stimulation as an adjunct therapy for obsessive-compulsive disorder: A randomized controlled study. Journal of Psychiatric Research 80, pages 30-37.
Crossref
Riccardo De Giorgi & Hugh Series. (2016) Treatment of Inappropriate Sexual Behavior in Dementia. Current Treatment Options in Neurology 18:9.
Crossref
H. Javelot. (2016) Psychopharmacologie de l’anxiété et de la dépression : aspects historiques, traitements actuels et perspectives. Annales Pharmaceutiques Françaises 74:2, pages 93-118.
Crossref
Fernanda Brito Melo-Felippe, Juliana Braga de Salles Andrade, Isabele Gomes Giori, Tamiris Vieira-Fonseca, Leonardo Franklin Fontenelle & Fabiana Barzotti Kohlrausch. (2015) Catechol-O-Methyltransferase Gene Polymorphisms in Specific Obsessive–Compulsive Disorder Patients’ Subgroups. Journal of Molecular Neuroscience 58:1, pages 129-136.
Crossref
Janet Treasure, Stephan Zipfel, Nadia Micali, Tracey Wade, Eric Stice, Angélica Claudino, Ulrike Schmidt, Guido K. Frank, Cynthia M. Bulik & Elisabet Wentz. (2015) Anorexia nervosa. Nature Reviews Disease Primers 1:1.
Crossref
Mujgan CengizSaide Nur OkutanBurcu BayogluAyse Sakalli KaniReha BayarNese Kocabasoglu. (2015) Genetic Polymorphism of the Serotonin Transporter Gene, SLC6A4 rs16965628, Is Associated with Obsessive Compulsive Disorder . Genetic Testing and Molecular Biomarkers 19:5, pages 228-234.
Crossref
Mark J. Millan, Guy M. Goodwin, Andreas Meyer-Lindenberg & Sven Ove Ögren. (2015) Learning from the past and looking to the future: Emerging perspectives for improving the treatment of psychiatric disorders. European Neuropsychopharmacology 25:5, pages 599-656.
Crossref
Daniele Serata, Georgios D. Kotzalidis, Chiara Rapinesi, Delfina Janiri, Simone Di Pietro, Gemma Callovini, Daria Piacentino, Carlotta Gasperoni, Roberto Brugnoli, Vittoria Rachele Ferri, Nicoletta Girardi, Roberto Tatarelli, Stefano Ferracuti, Gloria Angeletti, Paolo Girardi & Antonio Del Casale. (2015) Are 5-HT 3 antagonists effective in obsessive-compulsive disorder? A systematic review of literature . Human Psychopharmacology: Clinical and Experimental 30:2, pages 70-84.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.